|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 18,773.60 INR | -1.66% |
|
-0.43% | +23.59% |
| Market Cap | 241B 2.5B 2.18B 2.02B 1.85B 3.51B 3.57B 24.1B 9.47B 118B 9.39B 9.18B 406B | P/E 2027 * |
57.4x | P/E 2028 * | 41.6x |
|---|---|---|---|---|---|
| Enterprise Value | 244B 2.53B 2.21B 2.05B 1.88B 3.55B 3.61B 24.39B 9.58B 119B 9.5B 9.29B 411B | EV / Sales 2027 * |
10.6x | EV / Sales 2028 * | 8.73x |
| Free-Float |
62.24% | Yield 2027 * |
0.07% | Yield 2028 * | 0.1% |
Last Transcript: Neuland Laboratories Limited
| 1 day | -1.66% | ||
| 1 week | -0.43% | ||
| Current month | +0.77% | ||
| 1 month | +10.12% | ||
| 3 months | +25.25% | ||
| 6 months | +31.57% | ||
| Current year | +23.59% |
| 1 week | 18,580 | 19,848.45 | |
| 1 month | 16,713.95 | 20,072 | |
| Current year | 11,500 | 20,072 | |
| 1 year | 11,500 | 20,072 | |
| 3 years | 2,911.7 | 20,072 | |
| 5 years | 965.85 | 20,072 | |
| 10 years | 247.3 | 20,072 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 46 | 31/03/2026 | |
Abhijit Majumdar
DFI | Director of Finance/CFO | - | 22/11/2022 |
Ajitabh Singh
CTO | Chief Tech/Sci/R&D Officer | - | 28/02/2023 |
| Director | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 50 | 31/12/2001 | |
| Chairman | 82 | 06/01/1984 | |
| Director/Board Member | 46 | 28/02/2007 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| -1.66% | -0.43% | +22.71% | +532.71% | 2.55B | ||
| +1.01% | -3.76% | +48.29% | +161.92% | 1,031B | ||
| +1.11% | -3.49% | +51.74% | +57.19% | 595B | ||
| +3.27% | +0.99% | +32.42% | +87.18% | 431B | ||
| +0.42% | -1.16% | +29.43% | +23.64% | 326B | ||
| +1.03% | -0.84% | +29.58% | +45.15% | 277B | ||
| +0.49% | -5.44% | +21.00% | +23.80% | 263B | ||
| +1.59% | +4.89% | -22.56% | -37.35% | 224B | ||
| +2.85% | +1.62% | +23.57% | +62.17% | 193B | ||
| +2.97% | +0.53% | +23.40% | +74.96% | 164B | ||
| Average | +1.24% | -3.29% | +25.96% | +103.14% | 350.68B | |
| Weighted average by Cap. | +1.38% | -4.30% | +34.58% | +80.52% |
| 2027 * | 2028 * | |
|---|---|---|
| Net sales | 23.09B 240M 209M 194M 178M 336M 342M 2.31B 907M 11.27B 900M 880M 38.93B | 27.8B 288M 252M 233M 214M 405M 412M 2.78B 1.09B 13.57B 1.08B 1.06B 46.87B |
| Net income | 4.21B 43.68M 38.18M 35.31M 32.4M 61.33M 62.39M 421M 165M 2.06B 164M 160M 7.1B | 5.81B 60.25M 52.66M 48.7M 44.69M 84.59M 86.06M 581M 228M 2.84B 226M 221M 9.79B |
| Net Debt | 2.94B 30.48M 26.65M 24.64M 22.61M 42.8M 43.54M 294M 115M 1.43B 114M 112M 4.95B | 1.92B 19.93M 17.42M 16.11M 14.78M 27.98M 28.46M 192M 75.47M 938M 74.84M 73.19M 3.24B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/07/26 | ₹18,773.60 | -1.66% | 943 |
| 15/07/26 | ₹19,089.60 | +0.48% | 625 |
| 14/07/26 | ₹18,997.85 | -0.01% | 514 |
| 13/07/26 | ₹18,999.05 | -2.65% | 1,908 |
| 10/07/26 | ₹19,516.65 | -0.01% | 1,586 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- NEULANDLAB Stock
Select your edition
All financial news and data tailored to specific country editions

















